LOXL3 and diabetes mellitus: After 9 weeks, LOXL3 expression in diabetic rats showed a slight increase throughout the PDL (Figure 4A–D), but the difference was not statistically significant (Figure 4E; control group: MD=0.0556+0.0035; diabetes group: MD=0.0551±0.0067; p>0.05).